On 17 November 2026 China's National Medical Products Administration published its monthly record of medical device registrations approved during October 2026: 199 products in one batch, as carried by 中国食品药品网's republication of the NMPA notice. If you are weighing whether to come to China for imaging, screening or cancer workup, that announcement is the single most useful document in the chain, because it is where a device name stops being marketing language and becomes a registration number with a stated scope of application.
Most patients never see it. A hospital brochure or an agent's message will name a technology — AI-assisted reading of a low-dose lung CT, a deep-learning reconstruction on an MRI, an automated analysis on a pathology slide — and the patient has no cheap way to distinguish a registered indication from a sales claim. This batch is a good worked example of how to close that gap yourself.
What the October 2026 batch actually says
The announcement reports the composition of the batch by registration category:
| Category in the batch | Products approved |
|---|---|
| Domestic (mainland China) Class III | 169 |
| Imported Class III | 19 |
| Imported Class II | 8 |
| Hong Kong, Macao and Taiwan devices | 3 |
| Total | 199 |
Class III is the category Chinese regulators assign to higher-risk devices, which is where imaging systems and diagnostic software generally sit. The important structural point is that the body of the notice gives only these counts. Individual product names and registration certificate numbers are carried in the attachment to the announcement, not in the text you read on the news page. Readers who quote the "199" figure without opening that attachment have, in effect, read a headline and no more.
Two things follow. First, the 19 imported Class III certificates in a single month mean the register is a live document: devices made outside the mainland continue to be added, so an international patient who recognises an equipment platform from home is not automatically looking at something unregistered here. Second, the same fact cuts the other way — a familiar foreign brand name on a console proves nothing on its own. What proves it is an entry, imported or otherwise, with a certificate number and a scope.
The batch total is also not a verdict on any hospital. Nothing in this or any monthly list says that a given institution uses a registered product. It is a lookup table, and it only becomes evidence when you match a name from your own case file against it.
Three separate registers that patients collapse into one question
Verification fails most often because the wrong layer is being asked for the wrong document.
- The device. Imaging hardware, consumables and diagnostic software are checked against NMPA medical device registration — the register behind the 199-product batch. Software that produces a clinical read-out for a physician is handled as a device rather than as hospital IT, which is why an "AI module" needs its own entry.
- The medicine. Drug availability runs on a different list entirely. On 14 November 2026 the national healthcare security administration and the ministry of human resources and social security issued the 2026 basic medical insurance drug catalogue together with the commercial health insurance innovative drug catalogue, both effective 1 January 2027 (NHSA notice). If someone answers a question about a scanner by quoting a drug catalogue, the layers have been mixed.
- The institution and the clinician. A hospital's licence, its departments and the doctor reading your images are a third layer. None of them confer device-level registration on a piece of software.
A foreign CE mark, an overseas regulatory clearance or a published clinical study are not substitutes for a Chinese registration certificate. They are useful supporting evidence; they are not the record.
How to run an NMPA medical device registration check in four steps
This is the reverse-lookup workflow, from a name someone gave you to a number you can cite.
Step 1 — Get the claim in writing. Reply to the hospital's international medical department, or to the agent, and ask four things: the generic product name and model series, the manufacturer name, the registration certificate number, and the scope of application as printed on the certificate. A photograph of the certificate page is the fastest artefact and is standard to provide. If the answer arrives as a technology brand and a slogan and no number, the request has not been answered.
Step 2 — Find the approval record. Start from the NMPA monthly announcement of approved registrations, working backwards from the most recent batch — the 199-product list above is the October 2026 approvals. Open the attached catalogue and search the generic name or the manufacturer. Search by the marketing phrase you were sold and you will find nothing; this is where most self-checks break.
Step 3 — Match the scope, not the brand. Read the approved scope of application against the clinical question you actually have. A program registered for one organ, one modality or one finding is not a licence for whole-body screening. Off-scope use is the most common failure mode in AI claims, because the underlying technology is genuinely capable and the certificate is deliberately narrower than the demo.
Step 4 — Match the machine and the site. The model series named on the certificate should match the label on the physical unit in the branch you will attend, and the certificate should be inside its stated validity period. Large groups run multiple campuses and multiple vendors; ask which site, which room, which software version.
Ask one more question at the end of it: is the AI being used as a reader of record, or as a second opinion that a physician confirms? A diagnostic pathway is only as verifiable as the clinician's signature on it.
Which verification route gives you what
| Route | Evidence you end up holding | Effort on your side | Where it can fail |
|---|---|---|---|
| Self-check in the NMPA announcement and its attachment | Certificate-level: product name, registration number, approved scope | Minutes to an hour, plus tolerating a Chinese-language interface | Only counts appear in the notice body, so you must open the attachment; names outside recent batches are not covered |
| Document pack from the hospital's international department | Certificate plus device label for the unit you will actually use | One written request | Not every department has an English-language disclosure process, and some will send a brochure instead of a certificate |
| Agent or intermediary assertion, verbal or screenshotted | Usually nothing citable | None | No artefact to check; treat it as marketing until a number appears |
| Third-party pre-booking document review | The artefacts above, translated and matched to your indication | Handled for you | Can only verify what the hospital is prepared to disclose |
The practical conclusion is that the strongest position is the boring one: a certificate number in writing, found in the official record, with scope wording that matches your question.
Red flags in a device or AI claim
- A technology name and a photo of a machine, with no registration certificate number offered.
- A foreign CE mark or overseas approval presented as if it settled the Chinese status.
- "We are a top-tier hospital, so the software is fine" — institution and device are different layers.
- A screening claim broader than the indication that was disclosed to you.
- Refusal to name the site, model series or software version.
- Numbers quoted from the announcement's headline total as though they applied to that hospital's equipment.
What to do before you commit to a trip
Sequence matters. Decide the clinical question first, then the service, then the institution, then the device claim. The site's broader framework for that order is in the complete guide to medical tourism in China, and the shortlist of institutions that have an actual process for international patients is under hospitals.
For oncology workups, where AI imaging claims are loudest, start from the treatment pathway rather than the machine: cancer treatment in China and, where radiotherapy is the live question, the proton therapy guide. Screening-type requests are usually clearer as a structured package — see health checkups in Shanghai for foreigners. Booking is where document disclosure gets negotiated, and that is the stage our Shanghai hospital appointment service handles.
One boundary, stated plainly: registration status tells you a device or software is lawfully cleared for a defined use. It does not tell you that a test is right for you, and no article can. Any treatment plan must be assessed in person by a licensed physician.
Send the claim, get the check
If a hospital or an agent has named a specific scanner, AI module or software product to you, put that name, the certificate number if you have one, and a one-page clinical summary into our case evaluation form. OriEast works with the Chinese-language record, cross-checks the registration and scope wording, and returns what the documents do and do not support — before you buy a flight. For open questions about cost, timing or which department to approach, use the inquiry channel; translation, appointment booking and day-to-day coordination on the ground are part of the same engagement.